{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:23:52Z","timestamp":1777634632740,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10928-005-0049-8","type":"journal-article","created":{"date-parts":[[2005,11,13]],"date-time":"2005-11-13T06:22:09Z","timestamp":1131862929000},"page":"419-439","source":"Crossref","is-referenced-by-count":21,"title":["Population Pharmacokinetics of the Active Metabolite of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis"],"prefix":"10.1007","volume":"32","author":[{"given":"Jun","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Ludden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay O.","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"49_CR1","unstructured":"Prescribing Information for Arava Tablets (Leflunomide). March 2004"},{"key":"49_CR2","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","volume":"159","author":"V. Strand","year":"1999","journal-title":"Arch Intern. Med."},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U","volume":"43","author":"P. Tugwell","year":"2000","journal-title":"Arthritis. Rheum."},{"key":"49_CR4","first-page":"1983","volume":"28","author":"J.R. Kalden","year":"2001","journal-title":"J. Rheumatol."},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","volume":"353","author":"J.S. Smolen","year":"1999","journal-title":"Lancet"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/030097401300162897","volume":"30","author":"A. Larsen","year":"2001","journal-title":"Scand. J. Rheumatol."},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.60.10.913","volume":"60","author":"D.L. Scott","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U","volume":"43","author":"J.T. Sharp","year":"2000","journal-title":"Arthritis Rheum."},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/art.11015","volume":"8","author":"J.R. Kalden","year":"2003","journal-title":"Arthritis. Rheum."},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00003088-200241060-00003","volume":"41","author":"B. Rozman","year":"2002","journal-title":"Clin Pharmacokinet."},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P","volume":"42","author":"M.E. Weinblatt","year":"1999","journal-title":"Arthritis. Rheum."},{"key":"49_CR12","first-page":"551","volume":"23","author":"J. Li","year":"2002","journal-title":"Pharmacol. Sin."},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","volume":"35","author":"J.P. Davis","year":"1996","journal-title":"Biochemistry"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"29682","DOI":"10.1074\/jbc.270.50.29690","volume":"270","author":"L.D. Fairbanks","year":"1995","journal-title":"J. Biol Chem."},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00192310","volume":"14","author":"R.R. Bartlett","year":"1993","journal-title":"Springer. Semin. Immunopathol."},{"key":"49_CR16","unstructured":"J. T. Cassidy. Juvenile rheumatoid arthritis. In Kelley W.N., Harris E.D., Ruddy S., and C. B. Sledge (eds.) Textbook of Rheumatology. Fifth Edition. WB Saunders, 1996, 1207\u20131254"},{"key":"49_CR17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0889-857X(21)00130-7","volume":"17","author":"B. Nepom","year":"1991","journal-title":"Rheum. Dis. No. Amer."},{"key":"49_CR18","unstructured":"W. Weber and L. Harnisch: Use of a population approach to the development of leflunomide: A new disease-modifying drug in the treatment of rheumatoid arthritis. Hoechst Marion Roussel. COST B1 medicine, Geneva 1997, 239\u2013244"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"E.H. Giannini","year":"1997","journal-title":"Arth. Rheum."},{"key":"49_CR20","unstructured":"Beal S.L., Sheiner L.B. (Eds). NONMEM Users Guides. GloboMax, a Division of ICON plc, Hanover, MD, 1989\u20131998"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1023\/A:1016215116835","volume":"12","author":"E.I. Ette","year":"1995","journal-title":"Pharma. Res."},{"key":"49_CR22","volume-title":"Bayesian Data Analysis","year":"1995"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/dmd.31.10.1240","volume":"31","author":"A.S. Kalgutkar","year":"2003","journal-title":"Drug Metab Dispos."},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/ard.61.9.793","volume":"61","author":"G. Geborek","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.11452","volume":"49","author":"C. Siva","year":"2003","journal-title":"Arthritis Rheumatism (Arthritis Care & Research)"},{"key":"49_CR26","unstructured":"Silverman E., Spiegel L., and Jung L.K., et al. Efficacy and safety of leflunomide (LEF) versus methotrexate (MTX) in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA) Late-Breaking Abstracts. Program and abstracts of the American College of Rheumatology 67th Annual Scientific Meeting, October 23\u201328, 2003; Orlando, Florida. Abstract LB2"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-005-0049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-005-0049-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-005-0049-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T16:14:38Z","timestamp":1626711278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-005-0049-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":26,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s10928-005-0049-8","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}